Skip to Main Content

Paper Details

Antiretroviral Therapy Reduces T-cell Activation and Immune Exhaustion Markers in Human Immunodeficiency Virus Controllers.
Clin Infect Dis
27
2020
A5308, CD38, CD4+, CD8+, HIV, HIV DNA, HIV RNA, HIV-1 RNA, HLA, HLA-DR, Human, Human Immunodeficiency Virus, T-cell, emtricitabine, human immunodeficiency virus, human immunodeficiency virus (HIV) RNA, integrase, plasma, rilpivirine, tenofovir disoproxil fumarate
Author NameAffiliation
Michael C KeeferUniversity of Rochester School of Medicine and Dentistry
Mary CarringtonRagon Institute of MGH, Massachusetts General Hospital
Mary CarringtonFrederick National Laboratory for Cancer Research
Mary CarringtonRagon Institute of MGH, Massachusetts General Hospital
Mary CarringtonFrederick National Laboratory for Cancer Research
Daniel R KuritzkesBrigham and Women's Hospital, Harvard Medical School
Daniel R KuritzkesBrigham and Women's Hospital, Harvard Medical School
Paul E SaxBrigham and Women's Hospital, Harvard Medical School
  • 1 - 8

Datasets

Release 1.2